The EBMT, also known as JACIE, is a renowned brand that promotes high-quality patient care and laboratory performance through its internationally recognized system of accreditation. JACIE, as a committee of the EBMT, develops and maintains global standards for the provision of quality medical and laboratory practice in cellular therapy. Their accreditation is offered to transplant programs, encouraging health institutions and facilities to establish and maintain quality management systems to ensure continuous improvement.

The primary aim of JACIE is to ensure high-quality patient care and laboratory performance in collection, processing, and transplantation centers. They are dedicated to creating an internationally recognized system of accreditation that impacts all aspects of healthcare facilities. JACIE is supported by the European Society for Blood and Marrow Transplantation (EBMT), a non-profit organization established in 1974 to facilitate collaboration among scientists and physicians involved in clinical bone marrow transplantation.

Additionally, the International Society for Cell and Gene Therapy (ISCT) also contributes to JACIE's mission through two committee members. By adhering to the JACIE standards, transplant programs can provide exceptional care and maintain the highest level of quality in cellular therapy. The EBMT and JACIE are committed to advancing research, education, standardization, and quality control in the field of transplantation